CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
|Articles|December 16, 2011
Dr. Thomas Graf Discusses Geisinger's Improved Quality Scores in CMS' 5-Year Demonstration Project
Advertisement
Dr. Thomas Graf, Associate Chief Medical Officer, Population Health, Geisinger Health System, Danville, PA, who also serves as Chairman, Community Practice at Geisinger, discusses the health system’s participation in the Centers for Medicare Services’ 5-year Physician Group Practice (PGP) transitions demonstration project.
In addition, Dr. Graf also discusses Geisinger's improved quality scores during the pilot program, the out-of-control medical costs, and how the accountable care organization (ACO) model represents the best opportunity for transitioning healthcare from a volume-based to a value-based system.
Advertisement
Related to this article
Panelists ask whether cancer care will shift toward home-administered infusions as payers push for change. Other topics in this forward-looking session include new delivery tech and practice-led solutions.
CMS finalized Transparency in Coverage updates as a researcher warns ghost rates and missing inpatient data limit payer price files.
A traditional Medicare out-of-pocket (OOP) cap could reduce beneficiaries’ costs but increase annual federal spending by $39 billion to $96 billion.
MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
Build scalable obesity care with multidisciplinary teams, clear triage, and monitoring protocols; address GLP-1 gaps, Medicare access and price barriers, including oral GLP-1.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
CMS finalized the mandatory GLOBE Model, tying Part B drug rebates to international prices in areas covering 25% of beneficiaries from Jan. 1, 2027.
Advertisement
Advertisement
Trending on AJMC
1
Perspectives on Health-Related Social Needs for Medicare Advantage Beneficiaries
2
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
3
Psoriasis Is Much Rarer in Indigenous Groups Worldwide
4
Closing Screening Gaps for Cardio-Kidney-Metabolic Disease
5